Beyond Thinking
Welcome to Beyond Blue’s Thought Leadership Hub, where we highlight complex concepts with clarity and showcase our commitment to delivering excellence with ease. Explore our insights, discover innovative perspectives and join us on a journey to navigate the intricate with confidence.
PMRC 2026 Reflections
Authors: Sunny Shah, Head of US Insights, Alexandra Hunt, Research Manager, Beyond Blue Data is EVERYWHERE Clients are sitting on more data than ever, from an expanding range of sources. This is reshaping how they prioritize insights needs, allocate budgets, and...
Oops… We Did it Again: Lessons from music’s mistakes for AI-era qualitative analysis
Author: Phil Barnes, Research Director, Beyond Blue The 90s called, they want their dial-up internet back As a child of the early 90’s, I’m old enough to remember that horrible noise dial-up internet made, painstakingly rewinding VHS tapes, and waiting for teletext...
Beyond the Bubble: How to reach and really understand rare disease patients
Researching rare diseases isn’t just about gathering data. It’s about honoring people’s stories, working with empathy, and designing research that genuinely reflects the realities of small, often overlooked groups of individuals. Here’s what we think really matters...
Breast Cancer 2026: Navigating the forks in the road
Author: Siobhan Davies, Research Consultant, Beyond Blue 2025 delivered a remarkable volume of breast cancer data, with striking results across multiple subtypes and treatment settings. As we move into 2026, these advances need to find their place, and physicians are...
If Your Strategy Needs Explaining, it’s Already Failed
Author: Beyond Blue Strategy Team What comes to mind when you think of the word strategy? Maybe you picture something heavy and abstract, a maze of frameworks, or a workshop full of swirling post-its, or a pensive-looking individual in a black rollneck? In reality,...
Mind the (Trust) Gap
Authors: Jenny Fletcher - Marketing Director, Mike Pepp - Senior Commercial Consultant, Sam Hope - CEO, Beyond Blue Over the holidays, an article caught our eye: Trust Gap: Why Patients Turn to TikTok Instead of Pharmaceutical Messaging by the Global Healthy Living...
The BTKi Rollercoaster in MS Continues to Surprise
Author: Nikita Shah, Beyond Neurology The rollercoaster in the MS fairground has taken another sharp turn. Tolebrutinib has missed its primary endpoint in the Phase 3 PERSEUS trial in PPMS, and the already delayed FDA decision for its nrSPMS indication now looks...
Using Behavior Change Models to Ensure a More Holistic Assessment of Health Conditions
Behavior Change models condense many years of research on the influences shaping our actions. In healthcare market research, there continues to be significant focus on COM-B, given its wide applicability. We should not, however, overlook the potential contribution of...
Multiple Myeloma at ASH 2025: Navigating a rapidly evolving landscape
The multiple myeloma (MM) landscape continues to evolve at a rapid pace. Key data presented at ASH spanned CAR-T therapies (long-term data from CARTITUDE-4, iMMagine-1), bispecific antibodies (MAJESTEC-3), antibody–drug conjugates (long-term data from DREAMM-7 &...
